SCYX FY 2025 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$38M

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$21M+449.9% YoY

Gross Profit

$00.0% margin

Operating Income

-$16M-78.0% margin

Net Income

-$9M-41.8% margin

EPS (Diluted)

$-0.17

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$59M

Total Liabilities

$10M

Stockholders' Equity

$49M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$4M	+449.9%
Gross Profit	$0	$4M	-100.0%
Operating Income	-$16M	-$37M	+56.7%
Net Income	-$9M	-$21M	+59.6%